What's in Nina la Cour Freiesleben's pipeline?

Nina la Cour Freiesleben has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Nina la Cour Freiesleben's portfolio?

Top competitors by shared drug class: Ain Shams Maternity Hospital, Azienda USL Modena, Bezmialem Vakif University, Central Jutland Regional Hospital, D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nina-la-cour-freiesleben.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Nina la Cour Freiesleben — Portfolio Competitive Intelligence Brief

Nina la Cour Freiesleben pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
"Standard" rFSH dose	"Standard" rFSH dose	marketed	Gonadotropin	FSH receptor (FSHR)	Reproductive Medicine / Fertility
rFSH drug dose	rFSH drug dose	marketed	Gonadotropin	FSH receptor (FSHR)	Reproductive/Fertility

Therapeutic area mix

Reproductive Medicine / Fertility · 1
Reproductive/Fertility · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams Maternity Hospital · 1 shared drug class
Azienda USL Modena · 1 shared drug class
Bezmialem Vakif University · 1 shared drug class
Central Jutland Regional Hospital · 1 shared drug class
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology · 1 shared drug class
Dunamenti REK Istenhegyi IVF Center · 1 shared drug class
El Shatby University Hospital for Obstetrics and Gynecology · 1 shared drug class
AGUNCO Obstetrics and Gynecology Centre · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Nina la Cour Freiesleben:

Cite this brief

Drug Landscape (2026). Nina la Cour Freiesleben — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nina-la-cour-freiesleben. Accessed 2026-05-16.